You searched for Humanized antibody - Page 4 of 44 - Labiotech.eu

chemomab nash antibody peter thiel

More News! 5 Dec 2017

PayPal Co-Founder Backs Israeli Biotech Attacking NASH with an Antibody

…round of investment in ChemomAb, an Israeli startup developing a monoclonal antibody to treat nonalcoholic steatohepatitis (NASH). ChemomAb’s antibody, CM-101, is fully humanized and targets a newly discovered protein that…

December 5, 2017 - 2 minutesmins - By Evelyn Warner

netris pharma cancer treatment antibody

News and Trends 12 Dec 2018

Antibody Hitting Tumor Self-Destruct Button Passes Phase I

…antibody met the trial’s primary objective of good tolerability in the 19 recruited patients. In addition, the antibody helped to stabilize the disease and shrink tumors in patients with uterine…

December 12, 2018 - 2 minutesmins - By Jonathan Smith

Expert Advice 11 Dec 2019

What Makes a Successful Biotech?

…called Cambridge Antibody Technology. Almost 10 years later, the company’s antibody drug Humira — now the world’s best selling drug — was approved by the US FDA to treat rheumatoid…

December 11, 2019 - 12 minutesmins - By Helen Albert

Strep A streptococcus infection

News and Trends 12 Dec 2022

Antibody discovery could lead to new therapies to tackle Strep A

Researchers at Lund University in Sweden have discovered an antibody with the potential to protect against Strep A infection, as well as a rare form of antibody binding, that leads…

December 12, 2022 - 4 minutesmins - By Jim Cornall

ADVERTISEMENT

Morphosys Janssen Guselkumab approval psoriasis

News and Trends 18 Sep 2017

Update: After 25 years, MorphoSys Gets its First Antibody Approved

…psoriasis, bringing the first antibody developed by MorphoSys to the market. After celebrating its 25th anniversary last week, MorphoSys is welcoming the approval of the first antibody developed using its…

September 18, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

respiratory disease covid hospital

News and Trends 23 Nov 2022

Concern as study says new covid sub-variant is resistant to all therapeutic antibodies

…a new antibody therapy that is about to be approved in the U.S. highlights the importance of developing new antibody therapies against Covid-19. “The ever-increasing development of antibody resistance of…

November 23, 2022 - 4 minutesmins - By Jim Cornall

China biotech companies

Best in Biotech 16 Sep 2025

10 biotech companies in China you should know about

…candidate is ABO2011, which is currently being tested in a phase 1/2 trial as a monotherapy or in combination with the monoclonal antibody drug Toripalimab in patients with advanced solid…

September 16, 2025 - 14 minutesmins - By Willow Shah-Neville

First in class drug 2025

Best in Biotech 16 Jan 2025

Ten first-in-class drugs on track for FDA approval in 2025

…two main components: Monoclonal antibody (telisotuzumab): This antibody specifically binds to the c-Met protein on the surface of cancer cells. Cytotoxic agent (monomethyl auristatin E – MMAE): Once the antibody…

January 16, 2025 - 13 minutesmins - By Jules Adam

biotech companies in Germany

Best in Biotech 30 Jan 2024

Navigating German biotech: 13 key players to know

…have previously undergone immunotherapy. Another promising candidate is BNT327/PM8002, an anti-VEGF-A antibody fused with a humanized anti-PD-L1 (programmed cell death protein 1) VHH. Developed in partnership with Biotheus Inc., it…

January 30, 2024 - 18 minutesmins - By Jules Adam

numab intarcia autoimmune disease

News and Trends 31 Mar 2020

Swiss Biopharma Launches Second Cancer Antibody Deal with Japanese Pharma Giant

…rights to develop and commercialize an immuno-oncology drug candidate for an unspecified indication using Numab’s multi-specific antibody platform, MATCH. Antibody-based therapies are becoming increasingly popular in oncology, with Merck’s approved…

March 31, 2020 - 3 minutesmins - By David Kirk

shutterstock 489467578

News and Trends 16 Jan 2017

German Antibody for Cancer Diagnostics catches an Australian Eye

…Wilex, in Germany, for the worldwide rights to Redectane, an antibody with diagnostic applications in renal cancer. The antibody, Rencarex (girentuximab), which binds to the CAIX antigen on clear cell…

January 16, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Antibody

News and Trends 16 Nov 2022

Bio-Rad introduces pioneer antibody discovery platform for therapeutic development

…display library engineered to include more than 200 billion unique sequences and capable of identifying high-affinity antibody candidates using Bio-Rad’s newly developed SpyDisplay selection technology. The Pioneer antibody library is…

November 16, 2022 - 2 minutesmins - By Liza Laws